Cargando…

Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study

INTRODUCTION: There is limited evidence on therapies for obstructive hypertrophic cardiomyopathy (HCM), and data regarding treatment patterns and cost are scarce. This study assessed treatment patterns and economic outcomes in patients with symptomatic obstructive HCM. METHODS: Adults with symptomat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owens, Anjali T., Sutton, Megan B., Gao, Wei, Fine, Jennifer T., Xie, Jipan, Naidu, Srihari S., Desai, Nihar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135924/ https://www.ncbi.nlm.nih.gov/pubmed/35230625 http://dx.doi.org/10.1007/s40119-022-00257-7

Ejemplares similares

Association of Hypertrophic Obstructive Cardiomyopathy With Outcomes Following Transcatheter Aortic Valve Replacement
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2020)

A haemodynamic conundrum: a case report of a patient with concurrent pulmonary arterial hypertension and hypertrophic obstructive cardiomyopathy
por: Hassanin, Ahmed, et al.
Publicado: (2021)

How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
por: Jones, Brandon M., et al.
Publicado: (2017)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
por: Dong, Tiffany, et al.
Publicado: (2023)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM)
por: Langley, Paul C
Publicado: (2022)

The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
por: DeVries, J Hans, et al.
Publicado: (2023)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V.
Publicado: (2020)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
por: Sun, Jiejun, et al.
Publicado: (2022)

Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
por: Tian, Zhuang, et al.
Publicado: (2023)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Sex differences in clinical outcomes for obstructive hypertrophic cardiomyopathy in the USA: a retrospective observational study of administrative claims data
por: Butzner, Michael, et al.
Publicado: (2022)

Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument
por: Reaney, Matthew, et al.
Publicado: (2022)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy
por: Li, Peijin, et al.
Publicado: (2021)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Management of hypertrophic obstructive cardiomyopathy in prone position
por: Gosavi, Kundan S, et al.
Publicado: (2012)

Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis
por: Dawood, Mustafa, et al.
Publicado: (2018)

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)

Labour epidural analgesia in Hypertrophic Obstructive Cardiomyopathy
por: Sivakumar, Ranjith K, et al.
Publicado: (2019)

A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy
por: Murtha, Celeste M, et al.
Publicado: (2023)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

Contrast‐enhanced computed tomography with myocardial three‐dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy
por: Hamatani, Yasuhiro, et al.
Publicado: (2017)

Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization
por: Tripathi, Byomesh, et al.
Publicado: (2019)

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
por: Butzner, Michael, et al.
Publicado: (2022)

Pressure Tracings in Hypertrophic Cardiomyopathy With Dynamic Midventricular Obstruction
por: Jung, Hee-Chan, et al.
Publicado: (2012)

Ehlers-Danlos Syndrome associated with cardiomyopathy hypertrophic obstructive
por: Pinto, Raimundo José Almeida de Oliveira, et al.
Publicado: (2015)

Extended myectomy in the treatment of patients with hypertrophic obstructive cardiomyopathy
por: Kuć, Mateusz, et al.
Publicado: (2016)

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Smith, Joshua R., et al.
Publicado: (2018)

Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018)

Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Severe Midventricular Hypertrophic Obstructive Cardiomyopathy and Apical Aneurysm
por: Gibelli, Giuseppe, et al.
Publicado: (2013)

“Incompatible Housemates”: Hypertrophic Obstructive Cardiomyopathy and Takotsubo Syndrome
por: Sato, Yasue, et al.
Publicado: (2019)

Safety Monitoring for Obstructive Hypertrophic Cardiomyopathy During Exercise
por: Nakayama, Atsuko, et al.
Publicado: (2020)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8iiedf52lro5qnfsffct1nph8